clinical trial of effect of Silybum marianum extract capsules on systemic lupus erythematosus patients
Phase 2
- Conditions
- Systemic Lupus Erythematosus.Systemic lupus erythematosus (SLE)
- Registration Number
- IRCT20111105008013N9
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
age 18-50
having active lupus
Exclusion Criteria
diabetes
cardiovascular diseases
using irrelevant drugs with lupus
pregnancy
lactation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Score of Quality of life questionnaire. Timepoint: At the intervention begining and one month later. Method of measurement: Lupus QOL questionnaire.;Score of Systemic Lupus Erythematosus Activity questionnaire. Timepoint: At the intervention begining and one month later. Method of measurement: SLA questionnaire.
- Secondary Outcome Measures
Name Time Method Side effects. Timepoint: One month after the intervention beginning. Method of measurement: Observation.